相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2009)
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
R. J. Santen et al.
ENDOCRINE REVIEWS (2009)
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
Henning Mouridsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
Paul E. Goss et al.
CLINICAL BREAST CANCER (2008)
Tamoxifen: Catalyst for the change to targeted therapy
V. Craig Jordan
EUROPEAN JOURNAL OF CANCER (2008)
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
L. Mauriac et al.
ANNALS OF ONCOLOGY (2007)
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
P. Kelly Marcom et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
Alan S. Coates et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The early days of letrozole
Ajay S. Bhatnagar
BREAST CANCER RESEARCH AND TREATMENT (2007)
The discovery and mechanism of action of letrozole
Ajay S. Bhatnagar
BREAST CANCER RESEARCH AND TREATMENT (2007)
Phase II trial with letrozole (2.8mg) to maximal response as neoadjuvant endocrine therapy in postmenopausal patients with ER/PgR[+] operable breast cancer
A. Lombart-Cussac et al.
BREAST (2007)
Letrozole in advanced breast cancer: the PO25 trial
Henning T. Mouridsen
BREAST CANCER RESEARCH AND TREATMENT (2007)
A decade of letrozole: FACE
Joyce O'Shaughnessy
BREAST CANCER RESEARCH AND TREATMENT (2007)
Neoadjuvant endocrine therapy for locally advanced breast cancer
Cynthia X. Ma et al.
SEMINARS IN ONCOLOGY (2006)
Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats
NV Rajeshkumar et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L)
KM Wasan et al.
ANNALS OF ONCOLOGY (2005)
Aromatase inhibitors for breast cancer in postmenopausal women
SM Campos
ONCOLOGIST (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The pharmacology of letrozole
BP Haynes et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer
C Rose
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2003)
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:: Results of a phase III study of the international letrozole breast cancer group
H Mouridsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors
AS Bhatnagar et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
W Eiermann et al.
ANNALS OF ONCOLOGY (2001)
分享论文
